Facilitating world-class research
If the research is terminated prematurely or temporarily, it is the responsibility of the chief investigator (on behalf of the sponsor) to notify the MHRA (if applicable) and REC within 15 days explaining the reasons for this. Termination of clinical trials should be reported using the end of trial form.
Please inform CTRG promptly of any such suspension or early end. This applies to any research terminated early, for any reason, even if no participants have been recruited.